← Back
Data updated: Mar 10, 2026
EMCURE PHARMS LTD
Oncology
EMCURE PHARMS LTD is a generic drug manufacturer focused on Oncology. Key products include GEMCITABINE HYDROCHLORIDE.
2012
Since
7
Drugs
-
Trials
56
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
GEMCITABINE HYDROCHLORIDE 2025-09-16
Labeling
IRINOTECAN HYDROCHLORIDE 2025-08-20
Labeling
IRINOTECAN HYDROCHLORIDE 2025-08-20
Labeling
IRINOTECAN HYDROCHLORIDE 2025-08-20
Labeling
IRINOTECAN HYDROCHLORIDE 2025-08-20
Labeling
IRINOTECAN HYDROCHLORIDE 2025-08-20
Labeling
ATAZANAVIR SULFATE 2025-08-12
Labeling
ATAZANAVIR SULFATE 2025-08-12
Labeling
ATAZANAVIR SULFATE 2025-08-12
Labeling
GEMCITABINE HYDROCHLORIDE 2025-08-04
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (0)
Company Info
- First Approval
- 2012-02-14
- Latest
- 2020-08-24
- Applications
- 8
FDA Sponsor Names
EMCURE PHARMS LTDEMCURE PHARMS